The role of inflammation in CNS injury and disease
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
For many years, the central nervous system (CNS) was considered to be ‘immune privileged’, neither susceptible to nor contributing to inflammation. It is now appreciated that the CNS does exhibit features of inflammation, and in response to injury, infection or disease, resident CNS cells generate inflammatory mediators, including proinflammatory cytokines, prostaglandins, free radicals and complement, which in turn induce chemokines and adhesion molecules, recruit immune cells, and activate glial cells. Much of the key evidence demonstrating that inflammation and inflammatory mediators contribute to acute, chronic and psychiatric CNS disorders is summarised in this review. However, inflammatory mediators may have dual roles, with detrimental acute effects but beneficial effects in long‐term repair and recovery, leading to complications in their application as novel therapies. These may be avoided in acute diseases in which treatment administration might be relatively short‐term. Targeting interleukin (IL)‐1 is a promising novel therapy for stroke and traumatic brain injury, the naturally occurring antagonist (IL‐1ra) being well tolerated by rheumatoid arthritis patients. Chronic disorders represent a greater therapeutic challenge, a problem highlighted in Alzheimer's disease (AD); significant data suggested that anti‐inflammatory agents might reduce the probability of developing AD, or slow its progression, but prospective clinical trials of nonsteroidal anti‐inflammatory drugs or cyclooxygenase inhibitors have been disappointing. The complex interplay between inflammatory mediators, ageing, genetic background, and environmental factors may ultimately regulate the outcome of acute CNS injury and progression of chronic neurodegeneration, and be critical for development of effective therapies for CNS diseases. British Journal of Pharmacology (2006) 147, S232–S240. doi:10.1038/sj.bjp.0706400
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“As various neurological and psychiatric diseases have been associated with neuroinflammation in some post-mortem studies,183, 184, 185”
From Markers of microglia in post-mortem brain samples from patients with Alzheimer’s disease: a systematic review (2018) · cites this paper as [183]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Stroke is caused by ischaemia, leading to inflammation [900] and to the formation of ROS and other damaging free radicals [901] in the brain”
The cited source says what the claim attributes to it.
In the citing paper
“These processes induce adhesion molecules and, in order, mobilize immune and glial cells in a parallel and synergistic way (94, 126 -128).”
From Pituitary Dysfunction After Traumatic Brain Injury: A Clinical and Pathophysiological Approach (2015) · cites this paper as [127]
In the citing paper
“Thus, although this is not the focus of the present more physiologically based review, we recognise that many of relationships between ROSs and oxidative stress and overt progressive diseases may be mediated via the inflammatory signalling pathways involved in 'innate immunity' [900,1991-1993].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PLEIOTROPIC EFFECTS OF STATINS
Liao, J. K., & Laufs, U. (2005) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.45.120403.095748 · Cited by 1,994
Reactive Astrocytes Protect Tissue and Preserve Function after Spinal Cord Injury
Faulkner, J. R., Herrmann, J. E., Woo, M. J., Tansey, K. E., Doan, N. B., & Sofroniew, M. V. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.3547-03.2004 · Cited by 1,598 · cited 1×
“…for repair and recovery, but in fact this increases neuronal loss from the injury site and inhibits repair of the BBB and axonal remyelination (Faulkner et al., 2004), partly because astrocytes produce neurotrophic factors such as nerve growth factor and brain-derived growth factor that are…”
BackgroundMcGeer, P. L., Schulzer, M., & McGeer, E. G. (1996) · Neurology · doi:10.1212/wnl.47.2.425 · Cited by 1,367 · cited 1×
“Although other epidemiological studies also suggest a beneficial role for antiinflammatory agents in AD (McGeer et al., 1996), the general view from prospective trials of nonsteroidal inflammatory drugs (NSAIDs) is that they are disappointingly variable.”
BackgroundTNF neutralization in MS: Results of a randomized, placebo-controlled multicenter study
The Lenercept Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group (1999) · Neurology · doi:10.1212/wnl.53.3.457 · Cited by 1,017
Interleukin 1 in the brain: biology, pathology and therapeutic target
Rothwell, N. (2000) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01661-1 · Cited by 671 · cited 3×
“IL-1 was discovered as an important endogenous pyrogen, and is now recognised as the ‘prototypic inflammatory cytokine’ (reviewed by Rothwell & Luheshi, 2000).”
BackgroundInfluentialSelf-citationPerry, V. H. (2004) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2004.01.004 · Cited by 560 · cited 2×
“…metalloproteinase and iNOS activities, and breakdown of the BBB. Complications of its use however include inhibition of remyelination in MS models, and observations that microglial activation may be associated with anti-inflammatory cytokine expression rather than proinflammatory (Perry, 2004).”
BackgroundInflammation and the Degenerative Diseases of Aging
McGEER, P. L., & McGEER, E. G. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1332.007 · Cited by 518 · cited 1×
“The complement cascade is activated, and mRNAs for complement proteins are upregulated in PD (and AD) to a greater extent than in peripheral inflammatory diseases such as rheumatoid arthritis (reviewed by McGeer & McGeer, 2004).”
BackgroundScherbel, U., Raghupathi, R., Nakamura, M., Saatman, K. E., Trojanowski, J. Q., Neugebauer, E., Marino, M. W., & McIntosh, T. K. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.15.8721 · Cited by 415 · cited 1×
“…injury, the TNFa knockout mice show less behavioural impairment than the wild-type controls, but while the wild-type mice recovered in the weeks following injury, the knockout mice did not, remaining significantly impaired both in terms of histological damage and behaviour (Scherbel et al., 1999).”
BackgroundNew Insights into the Biology of the Acute Phase Response
Suffredini, A. F., Fantuzzi, G., Badolato, R., Oppenheim, J. J., & O'Grady, N. P. (1999) · Journal of Clinical Immunology · doi:10.1023/a:1020563913045 · Cited by 391 · cited 1×
“This represents another host defence mechanism which can limit proliferation of invading pathogens (Suffredini et al., 1999).”
BackgroundVezzani, A., Moneta, D., Richichi, C., Aliprandi, M., Burrows, S. J., Ravizza, T., Perego, C., & De Simoni, M. G. (2002) · Epilepsia · doi:10.1046/j.1528-1157.43.s.5.14.x · Cited by 386 · cited 1×
“Exogenous IL-1b enhances chemically induced seizures in rats and IL-1ra inhibits motor seizures and delays their onset (see Vezzani et al., 2002).”
Background
Cited by
Items 101–200 of 1,000
Inflammasome signaling at the heart of central nervous system pathology
Chakraborty, S., Kaushik, D. K., Gupta, M., & Basu, A. (2010) · Journal of Neuroscience Research · doi:10.1002/jnr.22343 · Cited by 187
“The levels of IL-1Ra have been found elevated by IFN-b treatment in MS patients (Lucas et al., 2006).”
BackgroundInfluentialHutchinson, P. J., O'Connell, M. T., Rothwell, N. J., Hopkins, S. J., Nortje, J., Carpenter, K. L. H., Timofeev, I., Al-Rawi, P. G., Menon, D. K., & Pickard, J. D. (2007) · Journal of Neurotrauma · doi:10.1089/neu.2007.0295 · Cited by 186
“In normal brain, the IL-1 system is expressed at low levels in cells and is up-regulated rapidly in response to local IL-1 (cid:4) , IL-1 (cid:5) , IL-1ra CONCENTRATIONS IN TRAUMATIC BRAIN INJURY or peripheral insults (Rothwell and Luheshi, 2000; Vitkovic et al., 2000; Lucas et al., 2006).”
Self-citationLu, J., Wu, D., Zheng, Y., Hu, B., Zhang, Z., Shan, Q., Zheng, Z., Liu, C., & Wang, Y. (2010) · The Journal of Pathology · doi:10.1002/path.2754 · Cited by 186
Clausen, F., Hånell, A., Björk, M., Hillered, L., Mir, A. K., Gram, H., & Marklund, N. (2009) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2009.06820.x · Cited by 184
“Numerous studies have suggested that the inflammatory response after TBI is mediated via the expression and release of cytokines, including the interleukins (Toulmond & Rothwell, 1995; Lucas et al., 2006; Morganti-Kossmann et al., 2007).”
BackgroundInfluentialExacerbated glial response in the aged mouse hippocampus following controlled cortical impact injury
Sandhir, R., Onyszchuk, G., & Berman, N. E. J. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2008.06.013 · Cited by 184
“Neuroinflammation following acute brain trauma plays a prominent role in both pathological and reconstructive response of the brain to injury (Lucas et al., 2006).”
BackgroundNeuroplasticity and brain repair after stroke
Cramer, S. C., & Riley, J. D. (2008) · Current Opinion in Neurology · doi:10.1097/wco.0b013e3282f36cb6 · Cited by 182
Safer anti-inflammatory therapy through dual COX-2/5-LOX inhibitors: A structure-based approach
P, J. J., Manju, S. L., Ethiraj, K. R., & Elias, G. (2018) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2018.06.003 · Cited by 182
Astrocytic Orosomucoid-2 Modulates Microglial Activation and Neuroinflammation
Jo, M., Kim, J.-H., Song, G. J., Seo, M., Hwang, E. M., & Suk, K. (2017) · The Journal of Neuroscience · doi:10.1523/jneurosci.2534-16.2017 · Cited by 180
“…diseases and other CNS disorders, including multiple sclerosis, stroke, traumatic brain injury, Parkinson’s disease, and Alzheimer’s disease (AD) (Akiyama et al., 2000; MorgantiKossmann et al., 2001; Lucas et al., 2006; Wang et al., 2007; Frischer et al., 2009; Tufekci et al., 2012).”
BackgroundUpdate on the treatment of spinal cord injury
Baptiste, D. C., & Fehlings, M. G. (2007) · Progress in Brain Research · doi:10.1016/s0079-6123(06)61015-7 · Cited by 178
Evaluation of the innate and adaptive immunity in type I and type II focal cortical dysplasias
Iyer, A., Zurolo, E., Spliet, W. G. M., Van Rijen, P. C., Baayen, J. C., Gorter, J. A., & Aronica, E. (2010) · Epilepsia · doi:10.1111/j.1528-1167.2010.02547.x · Cited by 178
“In particular the presence of the biologically active fragments of C3d indicates that the activation of the complement cascade has reached a point that may support a sustained inflammatory process [for review see (Lucas et al., 2006)].”
BackgroundGarcía-Bueno, B., Bioque, M., Mac-Dowell, K. S., Barcones, M. F., Martínez-Cengotitabengoa, M., Pina-Camacho, L., Rodríguez-Jiménez, R., Sáiz, P. A., Castro, C., Lafuente, A., et al. (2014) · Schizophrenia Bulletin · doi:10.1093/schbul/sbt001 · Cited by 177
Thurgur, H., & Pinteaux, E. (2019) · Neuroscience · doi:10.1016/j.neuroscience.2018.06.046 · Cited by 176
Neural circuit mechanisms of post–traumatic epilepsy
Hunt, R. F., Boychuk, J. A., & Smith, B. N. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00089 · Cited by 176
“…into the inner molecular layer to form functional recurrent excitatory connections with nearby granule cells during epileptogenesis (Cronin and Dudek, 1988; Cronin et al., 1992; Wuarin and Dudek, 1996, 2001; Lynch and Sutula, 2000; Winokur et al., 2004), a process termed “mossy fiber sprouting.””
BackgroundResultEffects of neuroinflammation on the regenerative capacity of brain stem cells
Russo, I., Barlati, S., & Bosetti, F. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.07168.x · Cited by 156
“Until fairly recently, the brain was considered an immunologically privileged site, not susceptible to immune activation due to the presence of the blood brain barrier (BBB) (Lucas et al. 2006).”
BackgroundQuinn, M. T., Ammons, M. C. B., & DeLeo, F. R. (2006) · Clinical Science · doi:10.1042/cs20060059 · Cited by 174
Oppenheim, H. A., Lucero, J., Guyot, A.-C., Herbert, L. M., McDonald, J. D., Mabondzo, A., & Lund, A. K. (2013) · Particle and Fibre Toxicology · doi:10.1186/1743-8977-10-62 · Cited by 171
“iNOS and IL-1β are common markers of neuroinflammation [54], which have been reported to be significantly up-regulated in the brain after exposure to traffic-generated air pollutants in both human exposure scenarios and animal studies [27,44].”
BackgroundModulation of astrocytic metabolic phenotype by proinflammatory cytokines
Gavillet, M., Allaman, I., & Magistretti, P. J. (2008) · Glia · doi:10.1002/glia.20671 · Cited by 149
“…and have been implicated in the pathogenesis of several neuropathological conditions such as in stroke, traumatic brain injury, epilepsy, infection, and neurodegenerative diseases such as multiple sclerosis, Parkinson’s disease or Alzheimer’s disease (Allan and Rothwell, 2001; Lucas et al., 2006).”
BackgroundInfluentialHypercholesterolemia in rats impairs the cholinergic system and leads to memory deficits
Ullrich, C., Pirchl, M., & Humpel, C. (2010) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2010.08.001 · Cited by 169
Van Zeller, M., Dias, D., Sebastião, A. M., & Valente, C. A. (2021) · Journal of Alzheimer's Disease · doi:10.3233/jad-210268 · Cited by 169
“However, although microglia and astrocytes have a crucial role as effectors of neuroinflammation, other cells, including neurons, express receptors for cytokines and other inflammatory mediators and can therefore participate in the coordinated inflammatory response within the CNS [25, 26].”
BackgroundCalcium signaling and gliotransmission in normal vs. reactive astrocytes
Agulhon, C., Sun, M.-Y., Murphy, T., Myers, T., Lauderdale, K., & Fiacco, T. A. (2012) · Frontiers in Pharmacology · doi:10.3389/fphar.2012.00139 · Cited by 167
“Additionally, activated/reactive microglia and astrocytes, and production of inflammatory mediators is also another common element in most, if not all, neurological, neuroinflammatory, and neurodegenerative disorders (Lucas et al., 2006).”
BackgroundSignificant roles of neuroinflammation in Parkinson’s disease: therapeutic targets for PD prevention
Lee, Y., Lee, S., Chang, S.-C., & Lee, J. (2019) · Archives of Pharmacal Research · doi:10.1007/s12272-019-01133-0 · Cited by 167
Cytokine and Growth Factor Activation In Vivo and In Vitro after Spinal Cord Injury
Garcia, E., Aguilar-Cevallos, J., Silva-Garcia, R., & Ibarra, A. (2016) · Mediators of Inflammation · doi:10.1155/2016/9476020 · Cited by 152
“and traumatic brain injury in rodents [228].”
Emerging Roles of microRNAs in Ischemic Stroke: As Possible Therapeutic Agents
Khoshnam, S. E., Winlow, W., Farbood, Y., Moghaddam, H. F., & Farzaneh, M. (2017) · Journal of Stroke · doi:10.5853/jos.2016.01368 · Cited by 154
Jiang, J., Quan, Y., Ganesh, T., Pouliot, W. A., Dudek, F. E., & Dingledine, R. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1218498110 · Cited by 165
“Brain inflammation is now recognized as a common feature of chronic neurodegenerative disorders, with the COX-2 cascade being widely believed to play a central role (36, 37).”
BackgroundGárate, I., García-Bueno, B., Madrigal, J. L., Bravo, L., Berrocoso, E., Caso, J. R., Micó, J. A., & Leza, J. C. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-151 · Cited by 165
“Moreover, the actions of IL-1b in the CNS include increases in the production of other pro-inflammatory cytokines which can stimulate enzymatic sources of oxidative and nitrosative mediators [45].”
BackgroundClausen, F., Hånell, A., Israelsson, C., Hedin, J., Ebendal, T., Mir, A. K., Gram, H., & Marklund, N. (2011) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2011.07723.x · Cited by 147
“European Journal of Neuroscience ª 2011 Federation of European Neuroscience Societies and Blackwell Publishing Ltd oxygen species and increased production of cytokines and prostaglandins (Herx et al., 2000; Lucas et al., 2006; Fogal & Hewett, 2008).”
BackgroundγH2AX as a molecular marker of aging and disease
Mah, L.-J., El-Osta, A., & Karagiannis, T. C. (2010) · Epigenetics · doi:10.4161/epi.5.2.11080 · Cited by 153
Stroke: Molecular mechanisms and therapies: Update on recent developments
Shehjar, F., Maktabi, B., Rahman, Z. A., Bahader, G. A., James, A. W., Naqvi, A., Mahajan, R., & Shah, Z. A. (2022) · Neurochemistry International · doi:10.1016/j.neuint.2022.105458 · Cited by 164
Kumar, R. G., Diamond, M. L., Boles, J. A., Berger, R. P., Tisherman, S. A., Kochanek, P. M., & Wagner, A. K. (2015) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2014.12.021 · Cited by 162
“…phases of injury (Kumar et al., 2014), particularly during the transition into recovery, may further inform the complex role that inflammation has after TBI and in defining what might be an appropriate timeline for considering treatment with anti-inflammatory interventions (Lucas et al., 2006).”
Bahar, E., Kim, J.-Y., & Yoon, H. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18091989 · Cited by 160
“As a result, these changes may lead to brain inflammation and neurotoxic reactive nitrogen species (RNS) generation [44].”
BackgroundCerciat, M., Unkila, M., Garcia‐Segura, L. M., & Arevalo, M. ‐. (2010) · Glia · doi:10.1002/glia.20904 · Cited by 160
“Two types of inflammatory responses are known to occur in the central nervous system (CNS): acute and chronic inflammation (Lucas et al., 2006).”
BackgroundGalindo, L. T., Filippo, T. R. M., Semedo, P., Ariza, C. B., Moreira, C. M., Câmara, N. O. S., & Porcionatto, M. A. (2011) · Neurology Research International · doi:10.1155/2011/564089 · Cited by 160
“Inflammatory molecules are important in healthy nervous tissue and their expression is promptly upregulated when an injury occurs [3].”
BackgroundOxidative Burst of Circulating Neutrophils Following Traumatic Brain Injury in Human
Liao, Y., Liu, P., Guo, F., Zhang, Z.-Y., & Zhang, Z. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068963 · Cited by 159
“Massive increase of local inflammatory mediators including cytokines and free radicals is well known following TBI which may eventually lead to complications of systemic hyperinflammation, followed by immunosuppression, multi-organ dysfunction syndrome (MODS) and even death, days to weeks after trauma [7,11,26].”
BackgroundInfluentialLotocki, G., de Rivero Vaccari, J. P., Perez, E. R., Sanchez-Molano, J., Furones-Alonso, O., Bramlett, H. M., & Dietrich, W. D. (2009) · Journal of Neurotrauma · doi:10.1089/neu.2008.0802 · Cited by 159
“Other strategies that target proin-flammatory cytokines or specific cellular adhesion molecules (Utagawa et al., 2008) leading to reduced infiltration of blood-borne leukocytes have also been reported (Lucas et al., 2006).”
InfluentialThe role of the microglia in acute CNS injury
Kawabori, M., & Yenari, M. A. (2015) · Metabolic Brain Disease · doi:10.1007/s11011-014-9531-6 · Cited by 141
“Chemokines, cytokines, and trophic factors Resting microglia release a variety of chemokines and cytokines, and pattern of this release is dramatically altered after CNS injury (Lucas et al. 2006).”
BackgroundMesenchymal Stem Cells in the Treatment of Traumatic Brain Injury
Hasan, A., Deeb, G., Rahal, R., Atwi, K., Mondello, S., Marei Mady, H. E. S., Gali, A., & Sleiman, E. (2017) · Frontiers in Neurology · doi:10.3389/fneur.2017.00028 · Cited by 141
“The glial scar encloses an area containing inhibitory molecules that prevents the regrowth of neurons (14) and inhibits the repair of the BBB (64).”
BackgroundHovens, I. B., Schoemaker, R. G., van der Zee, E. A., Heineman, E., Izaks, G. J., & van Leeuwen, B. L. (2012) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2012.06.004 · Cited by 155
Li, B., Mahmood, A., Lu, D., Wu, H., Xiong, Y., Qu, C., & Chopp, M. (2009) · Neurosurgery · doi:10.1227/01.neu.0000346272.76537.dc · Cited by 132
Zhang, S., Wang, X.-J., Tian, L.-P., Pan, J., Lu, G.-Q., Zhang, Y.-J., Ding, J.-Q., & Chen, S.-D. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-154 · Cited by 154
“To further confirm a relationship between CD200CD200R signalling and neuroinflammation in PD, we assayed several molecules that would be secreted by activated microglia in the proinflammatory stage [10,55-59].”
MethodBiphasic actions of HMGB1 signaling in inflammation and recovery after stroke
Hayakawa, K., Qiu, J., & Lo, E. H. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05728.x · Cited by 139
Kamat, P., Kalani, A., Givvimani, S., Pushpakumar, S. B., Tyagi, S. C., & Tyagi, N. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.07.051 · Cited by 153
“The brain has a complex pathophysiological process involving many factors, such as oxidative-stress-related free radical species and pro-inflammatory cytokines (Lucas et al., 2006).”
BackgroundCytokines and Brain Injury: Invited Review
Kadhim, H. J., Duchateau, J., & Sébire, G. (2008) · Journal of Intensive Care Medicine · doi:10.1177/0885066608318458 · Cited by 143
“are major mediators.(1-11) Several other molecular factors are also believed to take part in the aggravation of CNS injury and the causation of secondary brain damage.”
BackgroundInfluentialThe effect of concomitant peripheral injury on traumatic brain injury pathobiology and outcome
McDonald, S. J., Sun, M., Agoston, D. V., & Shultz, S. R. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0555-1 · Cited by 133
“Given TBI frequently features extensive damage to the blood-brain barrier [67, 68], the normally immune-privileged brain tissue becomes vulnerable to secondary insults from the periphery [69]; therefore, it could be speculated that polytrauma-induced SIRS may also influence the brain parenchyma, potentially exacerbati…”
Backgroundde Lanerolle, N. C., Lee, T.-S. W., & Spencer, D. D. (2010) · Neurotherapeutics · doi:10.1016/j.nurt.2010.08.002 · Cited by 152
Talbot, K., & Wang, H.-Y. (2014) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2013.12.007 · Cited by 140
“, stroke, Creutzfeld-Jakob disease, and multiple sclerosis) are associated with elevated brain levels of the same proinflammatory cytokines [129] that appear to induce brain insulin resistance in AD (Fig.”
BackgroundNLRP3 inflammasome in ischemic stroke: As possible therapeutic target
Alishahi, M., Farzaneh, M., Ghaedrahmati, F., Nejabatdoust, A., Sarkaki, A., & Khoshnam, S. E. (2019) · International Journal of Stroke · doi:10.1177/1747493019841242 · Cited by 153
The Role of Manganese Superoxide Dismutase in Inflammation Defense
Li, C., & Hai‐Meng, Z. H. O. U. (2011) · Enzyme Research · doi:10.4061/2011/387176 · Cited by 151
“secretion of mediators of inflammation such as cytokines, cyclooxygenase products, and kinins [7].”
BackgroundWatts, R. P., Thom, O., & Fraser, J. F. (2013) · Journal of Transplantation · doi:10.1155/2013/521369 · Cited by 150
“Briefly, IL-1β is a pleiotropic proinflammatorymediator that stimulates multiple pathways of inflammation after brain injury [88].”
BackgroundRole of inflammation in epilepsy and neurobehavioral comorbidities: Implication for therapy
Paudel, Y. N., Shaikh, M. F., Shah, S. Z., Kumari, Y., & Othman, I. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.08.020 · Cited by 152
Blood–brain barrier dysfunction following traumatic brain injury
Alluri, H., Wiggins-Dohlvik, K., Davis, M. L., Huang, J. H., & Tharakan, B. (2015) · Metabolic Brain Disease · doi:10.1007/s11011-015-9651-7 · Cited by 149
Rostène, W., Dansereau, M., Godefroy, D., Van Steenwinckel, J., Goazigo, A. R., Mélik‐Parsadaniantz, S., Apartis, E., Hunot, S., Beaudet, N., & Sarret, P. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07371.x · Cited by 133
Boer, K., Crino, P. B., Gorter, J. A., Nellist, M., Jansen, F. E., Spliet, W. G. M., Van Rijen, P. C., Wittink, F. R. A., Breit, T. M., Troost, D., et al. (2010) · Brain Pathology · doi:10.1111/j.1750-3639.2009.00341.x · Cited by 148
“The activation of inflammatory molecules is extensively described in both experimental models of epilepsy and human epilepsy tissue (28, 49, 80, 81), including epilepsy-associated malformations of cortical development (2, 4, 12, 61), suggesting a pathogenic role for inflammation in human epilepsy.”
BackgroundLee, J. H., Wei, Z. Z., Cao, W., Won, S., Gu, X., Winter, M., Dix, T. A., Wei, L., & Yu, S. P. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.09.013 · Cited by 135
Wasserman, J. K., Zhu, X., & Schlichter, L. C. (2007) · Brain Research · doi:10.1016/j.brainres.2007.08.058 · Cited by 148
Activation of the NLRP 3 inflammasome in microglia: the role of ceramide
Scheiblich, H., Schlütter, A., Golenbock, D. T., Latz, E., Martinez‐Martinez, P., & Heneka, M. T. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.14225 · Cited by 147
“The most extensively studied cytokine is the pro-inflammatory interleukin-1b (IL-1b), which has been linked to various disorders of the CNS that are associated with inflammatory processes, including AD, Parkinson’s disease, and multiple sclerosis (Allan et al. 2005; Lucas et al. 2006; Simi et al. 2007; Heneka et al. 2…”
BackgroundNutrition, Inflammation, and Cognitive Function
Wärnberg, J., Gomez‐Martinez, S., Romeo, J., Díaz, L., & Marcos, A. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2008.03985.x · Cited by 131
Wu, M. D., Hein, A. M., Moravan, M. J., Shaftel, S. S., Olschowka, J. A., & O’Banion, M. K. (2012) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2011.09.012 · Cited by 129
“Neuroinflammation is a feature of stroke, brain trauma, epilepsy, multiple sclerosis, Alzheimer’s disease, Parkinson’s disease, motor neuron disease, and movement disorders (Lucas et al., 2006).”
BackgroundO'Sullivan, J. B., Ryan, K. M., Curtin, N. M., Harkin, A., & Connor, T. J. (2009) · The International Journal of Neuropsychopharmacology · doi:10.1017/s146114570800967x · Cited by 146
Kim, S. Y., Buckwalter, M., Soreq, H., Vezzani, A., & Kaufer, D. (2012) · Epilepsia · doi:10.1111/j.1528-1167.2012.03701.x · Cited by 145
“…acute effects in PD. Correspondingly, various evidence suggests that the complex interplay between inflammatory mediators, aging, genetic background, and environmental factors may ultimately regulate the outcome of acute CNS injury and progression of chronic neurodegeneration (Lucas et al., 2006).”
BackgroundNeuroimmunology of the circadian clock
Coogan, A. N., & Wyse, C. A. (2008) · Brain Research · doi:10.1016/j.brainres.2008.07.087 · Cited by 145
Cho, H. J., Sajja, V. S. S. S., VandeVord, P. J., & Lee, Y. W. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.08.037 · Cited by 144
Novakovic, M. M., Korshunov, K. S., Grant, R. A., Martin, M. E., Abdala‐Valencia, H., Budinger, G. R. S., Radulović, J., & Prakriya, M. (2023) · Nature Communications · doi:10.1038/s41467-023-40968-6 · Cited by 145
Oxidative stress inhibits axonal transport: implications for neurodegenerative diseases
Fang, C., BOURDETTE, D. N., & Banker, G. A. (2012) · Molecular Neurodegeneration · doi:10.1186/1750-1326-7-29 · Cited by 145
“Our results also show that axons are more susceptible to ROS damage than nerve cell bodies and dendrites, so it is possible that more global changes in inflammation, which are hypothesized to play a role in several neurodegenerative diseases [12-15], could preferentially affect axons.”
BackgroundPeng, Y.-L., Liu, Y.-N., Liu, L., Wang, X., Jiang, C.-L., & Wang, Y.-X. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-75 · Cited by 127
“Cytokines such as interleukin (IL)-1β and IL-6 are elevated in the serum of depressed patients [2].”
BackgroundFiebich, B. L., Akter, S., & Akundi, R. S. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00260 · Cited by 127
“Inflammation could also result from an autoimmune response such as multiple sclerosis or in response to toxins and nerve agents (for general reviews, see Lucas et al., 2006; Aguzzi et al., 2013).”
BackgroundInfluentialThe role of the blood–CNS barrier in CNS disorders and their treatment
Palmer, A. M. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.07.029 · Cited by 117
Do cytokines have any role in epilepsy?
Sinha, S., Patil, S. A., Jayalekshmy, V., & Satishchandra, P. (2008) · Epilepsy Research · doi:10.1016/j.eplepsyres.2008.07.018 · Cited by 141
Lu, D., Tang, C., Yeh, W., Wong, K., Lin, C., Chen, Y., Lai, C., Chen, Y., Leung, Y., & Fu, W. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.03.001 · Cited by 137
Urinary tract infection after stroke
Stott, D. J., Falconer, A., Miller, H., Tilston, J., & Langhorne, P. (2009) · QJM · doi:10.1093/qjmed/hcp012 · Cited by 136
“In the acute phase, UTI-induced systemic inflammation and raised temperature(30) may increase the damage to vulnerable brain tissue in the ischaemic penumbra.(31,32) Infections also are associated with a catabolic response, with loss of skeletal muscle; this likely to be due to multiple complex factors, including infl…”
BackgroundKumar, M., Verma, S., & Nerurkar, V. R. (2010) · Journal of Neuroinflammation · doi:10.1186/1742-2094-7-73 · Cited by 122
“Broad spectrum and specific anti-inflammatory drugs such as IL-1ra and TACE-inhibitors are recommended as adjunct therapy to control disease progression of various neurodegenerative diseases such as stroke, cerebral ischemia, traumatic brain injury and MS [17,19].”
BackgroundInfluentialInflammation and Anti-Inflammatory Strategies for Alzheimer’s Disease – A Mini-Review
McNaull, B. B. A., Todd, S., McGuinness, B., & Passmore, A. P. (2010) · Gerontology · doi:10.1159/000237873 · Cited by 123
“Patients in early stages have reduced capacity to manage oxidative stress, evident through lower plasma antioxidant levels and altered antioxidant enzyme activity [ ,”
BackgroundGavins, F. N. E., Dalli, J., Flower, R. J., Granger, D. N., & Perretti, M. (2007) · The FASEB Journal · doi:10.1096/fj.06-7842com · Cited by 124
“The proinflammatory nature of IL-1 in several models of brain inflammation, including stroke, is well established (43, 44).”
BackgroundZhang, N., Zhang, X., Liu, X., Wang, H., Xue, J., Yu, J., Kang, N., & Wang, X. (2014) · Mediators of Inflammation · doi:10.1155/2014/370530 · Cited by 133
Toll-like receptors are key players in neurodegeneration
Arroyo, D. S., Soria, J. A., Gaviglio, E. A., Rodriguez-Galan, M. C., & Iribarren, P. (2011) · International Immunopharmacology · doi:10.1016/j.intimp.2011.05.006 · Cited by 117
“Several of thesemediators produced at the site of the inflammatory response generate local and systemic effects and therefore are key targets for therapeutic intervention in many diseases [1].”
BackgroundAl-Tamimi, Y., Orsi, N. M., Quinn, A., Homer‐Vanniasinkam, S., & Ross, S. A. (2010) · World Neurosurgery · doi:10.1016/j.wneu.2010.02.005 · Cited by 132
A neuroimmunological perspective on anxiety disorders
Hou, R., & Baldwin, D. S. (2012) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.1259 · Cited by 107
“Therefore, increased recognition of the role of cytokines in the CNS has opened important new areas for investigating the origin and treatment of neuropsychiatric disorders.”
BackgroundInfluentialMechanisms and Potential Therapeutic Applications of Microglial Activation after Brain Injury
Kim, J., Kim, N., & Yenari, M. A. (2015) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12360 · Cited by 118
“The pattern of this production changes drastically in the injured brain [129].”
BackgroundManghera, M., Ferguson-Parry, J., Lin, R., & Douville, R. N. (2016) · Journal of Virology · doi:10.1128/jvi.01503-16 · Cited by 118
The Neurobiology of Lipid Metabolism in Autism Spectrum Disorders
Tamiji, J., & Crawford, D. A. (2010) · Neurosignals · doi:10.1159/000323189 · Cited by 113
“Although the effects of the elevated level of PG metabolites in the nervous system need to be elucidated, the reported findings further support the presence of altered lipid biogenesis in ASDs. Involvement of Immunological FactorsEmerging evidence suggests that immunological factors might have an effect on brain devel…”
Erlandsson, A., Lin, C.-H. A., Yu, F., & Morshead, C. M. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2010.05.018 · Cited by 128
“Hence, our observations were consistent with previous work showing that immunocompromised animals display tissue degeneration however the progression is delayed (Lucas et al., 2006).”
Chen, S.-F., Hung, T., Chen, C.-C., Lin, K.-H., Huang, Y.-N., Tsai, H.-C., & Wang, J. (2007) · Life Sciences · doi:10.1016/j.lfs.2007.05.023 · Cited by 126
Targeted Activation of Astrocytes: A Potential Neuroprotective Strategy
Escartin, C., & Bonvento, G. (2008) · Molecular Neurobiology · doi:10.1007/s12035-008-8043-y · Cited by 125
“Some cytokines are typically described as detrimental, inducing excessive inflammatory processes and cell death in the brain, while others, used at an appropriate concentration, may have more physiological and even neuroprotective effects [17, 67, 68].”
BackgroundRole of Prostaglandins in Neuroinflammatory and Neurodegenerative Diseases
Lima, I. V. D. A., Bastos, L. F. S., Limborço‐Filho, M., Fiebich, B. L., & de Oliveira, A. C. P. (2012) · Mediators of Inflammation · doi:10.1155/2012/946813 · Cited by 127
“Then, it is presently clear that neuroinflammation is a key feature shared by many neurodegenerative disorders [8, 9].”
BackgroundAnti-TNF therapy in the injured spinal cord
Esposito, E., & Cuzzocrea, S. (2010) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2010.11.009 · Cited by 123
Dai, Y., Cao, X., Zhang, D., Li, X., Liu, W., & Jiang, G. (2019) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2019.03.009 · Cited by 122
Exercise-induced hippocampal anti-inflammatory response in aged rats
da Silva, S. G., Simões, P. S. R., Mortara, R. A., Scorza, F. A., Cavalheiro, É. A., Naffah‐Mazzacoratti, M. D. G., & Arida, R. M. (2013) · Journal of Neuroinflammation · doi:10.1186/1742-2094-10-61 · Cited by 122
“Indeed, increased levels of pro-inflammatory cytokines are reported in neurodegenerative disorders such as Parkinson’s disease, Alzheimer’s disease and other chronic conditions [7].”
BackgroundMacDowell, K. S., García-Bueno, B., Madrigal, J. L. M., Parellada, M., Arango, C., Micó, J. A., & Leza, J. C. (2013) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711001775 · Cited by 114
“Over the past two decades, inflammation, caused by both external and endogenous factors, has been implicated as a main pathophysiological feature of chronic mental illnesses, including schizophrenia (Lucas et al. 2006).”
BackgroundOsier, N. D., Carlson, S. W., DeSana, A. J., & Dixon, C. E. (2015) · Journal of Neurotrauma · doi:10.1089/neu.2014.3680 · Cited by 123
“cules, inflammatory mediator synthesis, edema, and immune cell invasion.(70) In the context of clinical TBI, inflammation represents a key pathophysiological process during both the acute and chronic periods and is replicated by experimental TBI.”
BackgroundSharma, R., Kambhampati, S. P., Zhang, Z., Sharma, A., Chen, S., Duh, E. I., Kannan, S., Tso, M. O. M., & Kannan, R. M. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.04.036 · Cited by 121
Johann, S., & Beyer, C. (2012) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2012.11.006 · Cited by 121
Glial Cells in Glaucoma: Friends, Foes, and Potential Therapeutic Targets
García-Bermúdez, M. Y., Freude, K., Mouhammad, Z. A., van Wijngaarden, P., Martin, K. R. G., & Kolko, M. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.624983 · Cited by 121
A murine model of mild traumatic brain injury exhibiting cognitive and motor deficits
Yang, S. H., Gustafson, J. D., Gangidine, M. M., Stepien, D. M., Schuster, R. M., Pritts, T. A., Goodman, M. D., Remick, D. G., & Lentsch, A. B. (2013) · Journal of Surgical Research · doi:10.1016/j.jss.2013.03.075 · Cited by 122
Antioxidants for the Prevention and Treatment of Non-communicable Diseases
Ayoka, T. O., Ezema, B. O., Eze, C. N., & Nnadi, C. O. (2022) · Journal of Exploratory Research in Pharmacology · doi:10.14218/jerp.2022.00028 · Cited by 119
Utagawa, A., Truettner, J. S., Dietrich, W. D., & Bramlett, H. M. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2008.02.001 · Cited by 119
“These findings regarding the detrimental consequences of early systemic inflammation on traumatic outcome do not address the later and possible beneficial response of inflammation after trauma (for review see Lucas et al., 2006).”
BackgroundThe Role of Glycogen Synthase Kinase 3 Beta in Neuroinflammation and Pain.
Maixner, D. W., & Weng, H.-R. (2013) · Journal of Pharmaceutics & Pharmacology · doi:10.13188/2327-204x.1000001 · Cited by 122
“The increase in astrocyte activation and proliferation produces the formation of a glial scar, isolating the damaged area from the rest of the CNS [118].”
BackgroundVascular and Inflammatory Factors in the Pathophysiology of Blast-Induced Brain Injury
Elder, G. A., Sosa, M. A. G., Gasperi, R. D., Stone, J. R., Dickstein, D. L., Haghighi, F. G., Hof, P. R., & Ahlers, S. T. (2015) · Frontiers in Neurology · doi:10.3389/fneur.2015.00048 · Cited by 118
“Cytokines cross the BBB either through active transport or damaged endothelium (144).”
BackgroundRuscher, K., Kuric, E., Liu, Y., Walter, H. L., Issazadeh-Navikas, S., Englund, E., & Wieloch, T. (2013) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2013.71 · Cited by 114
NADPH oxidases in traumatic brain injury – Promising therapeutic targets?
Ma, M. W., Wang, J., Dhandapani, K. M., Wang, R., & Brann, D. W. (2018) · Redox Biology · doi:10.1016/j.redox.2018.03.005 · Cited by 117
“In the long-term, acute inflammatory processes can become self-perpetuating, leading to sustained neuroinflammation that is detrimental [136,137].”
BackgroundThe spleen contributes to stroke induced neurodegeneration through interferon gamma signaling
Seifert, H. A., Leonardo, C. C., Hall, A. A., Rowe, D. D., Collier, L. A., Benkovic, S. A., Willing, A. E., & Pennypacker, K. R. (2012) · Metabolic Brain Disease · doi:10.1007/s11011-012-9283-0 · Cited by 117
“or protection (Lucas et al. 2006; Boutin et al. 2001).”
Chen, C.-C., Hung, T., Lee, C. Y., Wang, L.-F., Wu, C., Ke, C., & Chen, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0115694 · Cited by 117
“Of the numerous neurotoxic factors released by activated glial cells, the consequences of upregulated iNOS, COX-2, cytokine and chemokine expression have been well established [44].”
Background
Metadata
- Authors
- Lucas, S., Rothwell, N. J., & Gibson, R. M.
- Affiliations
- University of Manchester (GB)
- HSE Science and Research Centre (GB)
- Corresponding author
- Rothwell, Nancy J
- ORCID
- Rothwell, Nancy J
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2006-01
- Volume
- 147
- Issue
- S1
- Pages
- S232-40
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- PMC
- PMC1760754
- OpenAlex
- W1594425991
- Cited by
- 1,272
- References
- 41
- Citations by year
- 2026: 12 · 2025: 37 · 2024: 32 · 2023: 57 · 2022: 65 · 2021: 69 · 2020: 62 · 2019: 80 · 2018: 67 · 2017: 67 · 2016: 60 · 2015: 89 · 2014: 77 · 2013: 79 · 2012: 62
- FWCI
- 7.38
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- British Journal of Pharmacology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Health Sciences › Medicine › Clinical Neurology › Traumatic Brain Injury and Neurovascular Disturbances
- Keywords
- neuroinflammation, central nervous system injury, immune privilege, inflammatory cytokines, prostaglandins, free radicals, complement system, chemokines, glial activation, interleukin-1, interleukin-1 receptor antagonist, stroke, traumatic brain injury, Alzheimer's disease, anti-inflammatory therapy, neurodegeneration, aging
- MeSH terms
- Acute Disease, Animals, Brain, Central Nervous System Diseases, Chronic Disease, Craniocerebral Trauma, Humans, Inflammation, Inflammation Mediators
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.